{"id":25100,"date":"2018-10-01T17:29:11","date_gmt":"2018-10-01T17:29:11","guid":{"rendered":"https:\/\/beyondtype2.org\/resources\/noticias-de-ultima-hora-desde-easd2018\/"},"modified":"2018-10-01T17:29:11","modified_gmt":"2018-10-01T17:29:11","slug":"noticias-de-ultima-hora-desde-easd2018","status":"publish","type":"resources","link":"https:\/\/beyondtype1.org\/es\/noticias-de-ultima-hora-desde-easd2018\/","title":{"rendered":"Noticias de \u00faltima hora desde #EASD2018"},"content":{"rendered":"<p><strong>Esta p&aacute;gina fue actualizada por&nbsp;&uacute;ltima vez el 01 de Oct, 2018 a las &nbsp;7:40 am&nbsp;<\/strong><strong>PT&nbsp;<\/strong><\/p>\n<p><em><strong>Nota de editor:<\/strong><\/em> este art&iacute;culo ser&aacute; actualizado con frecuencia con noticias de &uacute;ltima hora y anuncios durante el curso del &nbsp;<a href=\"https:\/\/www.easd.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">Congreso de la Asociaci&oacute;n Europea para el Estudio de la Diabetes .<\/a>&nbsp; &iexcl;Regresa con frecuencia! Sigue los mensajes en twitter con el hashtag &nbsp;<a href=\"https:\/\/twitter.com\/hashtag\/EASD2018\" target=\"_blank\" rel=\"noopener noreferrer\">#EASD2018<\/a>.<\/p>\n<p><strong>Lunes 1 de octubre, 2018<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Abbott <a href=\"http:\/\/abbott.mediaroom.com\/2018-10-01-Abbott-s-FreeStyle-R-Libre-2-with-Optional-Real-Time-Alarms-Secures-CE-Mark-for-Use-in-Europe?sf198905542=1\" target=\"_blank\" rel=\"noopener noreferrer\">anuncia<\/a> la marca CE para su sistema FreeStyle Libre 2. Este sistema ofrecer&aacute; alarmas opcionales para glucosa baja y alta por medio de tecnolog&iacute;a Bluetooth&nbsp;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">En <a href=\"https:\/\/www.easd-industry.com\/programme\/from-science-to-reality-understanding-the-silent-side-of-severe-hypoglycemia\" target=\"_blank\" rel=\"noopener noreferrer\">simposio<\/a> patrocinado por los laboratorios Lilly, el profesor Thomas Danne y otros expertos, entre ellos la paciente y experta Crystal Bowersox presentan la necesidad de educaci&oacute;n en diabetes con relaci&oacute;n al impacto y consecuencia de hipoglucemias severa y la importancia de establecer junto con el equipo al cuidado de la salud, metas gluc&eacute;micas y objetivos para reducir la incidencia de las mismas.&nbsp;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Semaglutida: reducci&oacute;n consistente comprobada de 1.4 a 1.6% en valores de HbA1c en el <\/span><a href=\"https:\/\/diabetes.medicinematters.com\/semaglutide\/type-2-diabetes\/a-quick-guide-to-the-sustain-trials\/12206922\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">programa del Estudio SUSTAIN.<\/span><\/a><span style=\"font-weight: 400;\"> Del simposio de <\/span><a href=\"https:\/\/twitter.com\/NovoNordiskLive\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">@NovoNordiskLive<\/span><\/a><span style=\"font-weight: 400;\"> en <\/span><a href=\"https:\/\/twitter.com\/search?q=%23EASD2018\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">#EASD2018<\/span><\/a><\/li>\n<\/ul>\n<p><strong>Martes 2 de octubre, 2018<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">El estudio <\/span><a href=\"https:\/\/www.epgonline.org\/us\/news\/positive-results-in-pioneer-3-trial-of-oral-semaglutide-versus-sitagliptin-for-type-2-diabetes----novo-nordisk.html\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">PIONEER<\/span><\/a><span style=\"font-weight: 400;\"> 1 demostr&oacute; que, a comparaci&oacute;n del uso de placebo, la toma diaria de Semaglutida se relacion&oacute; con reducci&oacute;n importante en HbA1c, peso corporal y ambos en adultos con diabetes Tipo 2. <\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Profesor Jaakko Tuomilehto &ldquo;La p&eacute;rdida temprana de peso predice un efecto preventivo de diabetes Tipo 2&rdquo;. Las intervenciones en estilo de vida tempranas tienen &eacute;xito en esta prevenci&oacute;n. <\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Roche y Novo Nordisk trabajar&aacute;n juntos para integrar informaci&oacute;n de dosificaci&oacute;n de la pluma con conexi&oacute;n de Novo Nordisk al ecosistema abierto de Roche, comunicando esta informaci&oacute;n con sus soluciones digitales para el manejo de la diabetes incluyendo a mySugr, de acuerdo a su <\/span><a href=\"https:\/\/assets.mysugr.com\/website\/mysugr.com-wordpress\/uploads\/2018\/10\/201810-Novo.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">comunicado de prensa<\/span><\/a><\/li>\n<li><span style=\"font-weight: 400;\">La Asociaci&oacute;n Europea para el Estudio de la Diabetes (EASD, por sus siglas en ingl&eacute;s) ha anunciado el lanzamiento de una nueva coalici&oacute;n, el Foro Europeo de Diabetes (<\/span><a href=\"https:\/\/www.eudf.org\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">EUDF<\/span><\/a><span style=\"font-weight: 400;\">, por sus siglas en ingl&eacute;s). El llamado a la acci&oacute;n de este foro publica las causas identificadas de falla en el sistema Europeo de salud para el manejo de una condici&oacute;n cr&oacute;nica, compleja y en aumento como la diabetes y propone soluciones probables para estos temas. <\/span><\/li>\n<\/ul>\n\n","protected":false},"excerpt":{"rendered":"<p>Esta p&aacute;gina fue actualizada por&nbsp;&uacute;ltima vez el 01 de Oct, 2018 a las &nbsp;7:40 am&nbsp;PT&nbsp; Nota de editor: este art&iacute;culo ser&aacute; actualizado con frecuencia con noticias de &uacute;ltima hora y anuncios durante el curso del &nbsp;Congreso de la Asociaci&oacute;n Europea para el Estudio de la Diabetes .&nbsp; &iexcl;Regresa con frecuencia! Sigue los mensajes en twitter [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":25101,"comment_status":"open","ping_status":"open","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-25100","resources","type-resources","status-publish","has-post-thumbnail","hentry","diabetes-types-tipo-1","tags-noticias"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Noticias de \u00faltima hora desde #EASD2018 | Beyond Type 1<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/beyondtype1.org\/es\/noticias-de-ultima-hora-desde-easd2018\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Noticias de \u00faltima hora desde #EASD2018 | Beyond Type 1\" \/>\n<meta property=\"og:description\" content=\"Esta p&aacute;gina fue actualizada por&nbsp;&uacute;ltima vez el 01 de Oct, 2018 a las &nbsp;7:40 am&nbsp;PT&nbsp; Nota de editor: este art&iacute;culo ser&aacute; actualizado con frecuencia con noticias de &uacute;ltima hora y anuncios durante el curso del &nbsp;Congreso de la Asociaci&oacute;n Europea para el Estudio de la Diabetes .&nbsp; &iexcl;Regresa con frecuencia! Sigue los mensajes en twitter [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/beyondtype1.org\/es\/noticias-de-ultima-hora-desde-easd2018\/\" \/>\n<meta property=\"og:site_name\" content=\"Beyond Type 1\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/beyondtype1\" \/>\n<meta property=\"og:image\" content=\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-HEADER-EASD-ULTIMA-HORA.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2048\" \/>\n\t<meta property=\"og:image:height\" content=\"733\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@BeyondType1\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/beyondtype1.org\/es\/noticias-de-ultima-hora-desde-easd2018\/\",\"url\":\"https:\/\/beyondtype1.org\/es\/noticias-de-ultima-hora-desde-easd2018\/\",\"name\":\"Noticias de \u00faltima hora desde #EASD2018 | Beyond Type 1\",\"isPartOf\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/noticias-de-ultima-hora-desde-easd2018\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/noticias-de-ultima-hora-desde-easd2018\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-HEADER-EASD-ULTIMA-HORA.jpg\",\"datePublished\":\"2018-10-01T17:29:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/noticias-de-ultima-hora-desde-easd2018\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/beyondtype1.org\/es\/noticias-de-ultima-hora-desde-easd2018\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/beyondtype1.org\/es\/noticias-de-ultima-hora-desde-easd2018\/#primaryimage\",\"url\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-HEADER-EASD-ULTIMA-HORA.jpg\",\"contentUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-HEADER-EASD-ULTIMA-HORA.jpg\",\"width\":2048,\"height\":733},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/beyondtype1.org\/es\/noticias-de-ultima-hora-desde-easd2018\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/beyondtype1.org\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Noticias de \u00faltima hora desde #EASD2018\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#website\",\"url\":\"https:\/\/beyondtype1.org\/es\/\",\"name\":\"Beyond Type 1\",\"description\":\"Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research.\",\"publisher\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/beyondtype1.org\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#organization\",\"name\":\"Beyond Type 1\",\"url\":\"https:\/\/beyondtype1.org\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg\",\"contentUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg\",\"width\":56,\"height\":56,\"caption\":\"Beyond Type 1\"},\"image\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/beyondtype1\",\"https:\/\/x.com\/BeyondType1\",\"http:\/\/instagram.com\/BeyondType1\/\",\"https:\/\/www.youtube.com\/c\/BeyondType1\",\"https:\/\/www.tiktok.com\/@beyondtype1\",\"https:\/\/www.linkedin.com\/company\/beyond-type1\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Noticias de \u00faltima hora desde #EASD2018 | Beyond Type 1","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/beyondtype1.org\/es\/noticias-de-ultima-hora-desde-easd2018\/","og_locale":"es_ES","og_type":"article","og_title":"Noticias de \u00faltima hora desde #EASD2018 | Beyond Type 1","og_description":"Esta p&aacute;gina fue actualizada por&nbsp;&uacute;ltima vez el 01 de Oct, 2018 a las &nbsp;7:40 am&nbsp;PT&nbsp; Nota de editor: este art&iacute;culo ser&aacute; actualizado con frecuencia con noticias de &uacute;ltima hora y anuncios durante el curso del &nbsp;Congreso de la Asociaci&oacute;n Europea para el Estudio de la Diabetes .&nbsp; &iexcl;Regresa con frecuencia! Sigue los mensajes en twitter [&hellip;]","og_url":"https:\/\/beyondtype1.org\/es\/noticias-de-ultima-hora-desde-easd2018\/","og_site_name":"Beyond Type 1","article_publisher":"https:\/\/www.facebook.com\/beyondtype1","og_image":[{"width":2048,"height":733,"url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-HEADER-EASD-ULTIMA-HORA.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@BeyondType1","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/beyondtype1.org\/es\/noticias-de-ultima-hora-desde-easd2018\/","url":"https:\/\/beyondtype1.org\/es\/noticias-de-ultima-hora-desde-easd2018\/","name":"Noticias de \u00faltima hora desde #EASD2018 | Beyond Type 1","isPartOf":{"@id":"https:\/\/beyondtype1.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/beyondtype1.org\/es\/noticias-de-ultima-hora-desde-easd2018\/#primaryimage"},"image":{"@id":"https:\/\/beyondtype1.org\/es\/noticias-de-ultima-hora-desde-easd2018\/#primaryimage"},"thumbnailUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-HEADER-EASD-ULTIMA-HORA.jpg","datePublished":"2018-10-01T17:29:11+00:00","breadcrumb":{"@id":"https:\/\/beyondtype1.org\/es\/noticias-de-ultima-hora-desde-easd2018\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/beyondtype1.org\/es\/noticias-de-ultima-hora-desde-easd2018\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/beyondtype1.org\/es\/noticias-de-ultima-hora-desde-easd2018\/#primaryimage","url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-HEADER-EASD-ULTIMA-HORA.jpg","contentUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-HEADER-EASD-ULTIMA-HORA.jpg","width":2048,"height":733},{"@type":"BreadcrumbList","@id":"https:\/\/beyondtype1.org\/es\/noticias-de-ultima-hora-desde-easd2018\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/beyondtype1.org\/es\/"},{"@type":"ListItem","position":2,"name":"Noticias de \u00faltima hora desde #EASD2018"}]},{"@type":"WebSite","@id":"https:\/\/beyondtype1.org\/es\/#website","url":"https:\/\/beyondtype1.org\/es\/","name":"Beyond Type 1","description":"Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research.","publisher":{"@id":"https:\/\/beyondtype1.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/beyondtype1.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/beyondtype1.org\/es\/#organization","name":"Beyond Type 1","url":"https:\/\/beyondtype1.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg","contentUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg","width":56,"height":56,"caption":"Beyond Type 1"},"image":{"@id":"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/beyondtype1","https:\/\/x.com\/BeyondType1","http:\/\/instagram.com\/BeyondType1\/","https:\/\/www.youtube.com\/c\/BeyondType1","https:\/\/www.tiktok.com\/@beyondtype1","https:\/\/www.linkedin.com\/company\/beyond-type1\/"]}]}},"_links":{"self":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources\/25100","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/types\/resources"}],"author":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/comments?post=25100"}],"version-history":[{"count":0,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources\/25100\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/media\/25101"}],"wp:attachment":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/media?parent=25100"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}